207 related articles for article (PubMed ID: 36990678)
1. Epidemiology of Helicobacter in Chinese families: a foundation for cost-effective eradication strategies?
Marshall B
Gut; 2024 Apr; 73(5):870-871. PubMed ID: 36990678
[No Abstract] [Full Text] [Related]
2. Varying efficacy of Helicobacter pylori eradication regimens: cost effectiveness study using a decision analysis model.
Duggan AE; Tolley K; Hawkey CJ; Logan RF
BMJ; 1998 May; 316(7145):1648-54. PubMed ID: 9603748
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness Analysis of Helicobacter pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model.
Han Y; Yan T; Ma H; Yao X; Lu C; Li Y; Li L
Dig Dis Sci; 2020 Jun; 65(6):1679-1688. PubMed ID: 31673902
[TBL] [Abstract][Full Text] [Related]
4. The cost effectiveness of Helicobacter pylori population screening-economic evaluation alongside a randomised controlled trial with 13-year follow-up.
Høgh MB; Kronborg C; Hansen JM; Schaffalitzky de Muckadell OB
Aliment Pharmacol Ther; 2019 Apr; 49(8):1013-1025. PubMed ID: 30854700
[TBL] [Abstract][Full Text] [Related]
5. Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication.
Kowada A
Dig Dis Sci; 2021 Dec; 66(12):4220-4226. PubMed ID: 33417196
[TBL] [Abstract][Full Text] [Related]
6. Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost-effectiveness analysis.
Kowada A; Asaka M
Helicobacter; 2022 Jun; 27(3):e12886. PubMed ID: 35343031
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis and effectiveness of pharmacist-managed outpatient clinics in Helicobacter pylori eradication therapy.
Seko T; Tachi T; Hatakeyama H; Noguchi Y; Teramachi H
Int J Clin Pract; 2019 Jun; 73(6):e13349. PubMed ID: 30912226
[TBL] [Abstract][Full Text] [Related]
8. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
9. Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials.
Lin LC; Hsu TH; Huang KW; Tam KW
World J Gastroenterol; 2016 Jun; 22(23):5445-53. PubMed ID: 27340362
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of a tailored Helicobacter pylori eradication strategy based on the presence of a 23S ribosomal RNA point mutation that causes clarithromycin resistance in Korean patients.
Cho JH; Jeon SR; Kim HG; Jin SY; Park S
J Gastroenterol Hepatol; 2019 Apr; 34(4):700-706. PubMed ID: 30011083
[TBL] [Abstract][Full Text] [Related]
11. Eradication rate of Helicobacter pylori reinfection in Korea: A retrospective study.
Choi YK; Ahn JY; Won SH; Jung K; Na HK; Jung KW; Kim DH; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY
J Gastroenterol Hepatol; 2019 Oct; 34(10):1696-1702. PubMed ID: 30811663
[TBL] [Abstract][Full Text] [Related]
12. Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis.
Kowada A; Asaka M
Helicobacter; 2021 Oct; 26(5):e12837. PubMed ID: 34278663
[TBL] [Abstract][Full Text] [Related]
13. Three-Decade Failure to the Eradication of Refractory
Moghadam MT; Chegini Z; Norouzi A; Dousari AS; Shariati A
Curr Pharm Biotechnol; 2021; 22(7):945-959. PubMed ID: 32767919
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials.
Lü M; Yu S; Deng J; Yan Q; Yang C; Xia G; Zhou X
PLoS One; 2016; 11(10):e0163743. PubMed ID: 27723762
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease.
Jönsson B
Scand J Gastroenterol Suppl; 1996; 215():90-5. PubMed ID: 8722390
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of helicobacter pylori eradication as an upfront treatment of secondary immune thrombocytopenia: an experience from Pakistan.
Sultan S; Irfan SM; Kaker J; Hasan M
Med J Malaysia; 2016 Apr; 71(2):53-6. PubMed ID: 27326941
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori-associated ulcer bleeding: should we test for eradication after treatment?
Pohl H; Finlayson SR; Sonnenberg A; Robertson DJ
Aliment Pharmacol Ther; 2005 Sep; 22(6):529-37. PubMed ID: 16167969
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication.
Kajihara Y; Shimoyama T; Mizuki I
Scand J Gastroenterol; 2017 Feb; 52(2):238-241. PubMed ID: 27806639
[TBL] [Abstract][Full Text] [Related]
19. Global whole family based-
Ding SZ
World J Gastroenterol; 2020 Mar; 26(10):995-1004. PubMed ID: 32205991
[No Abstract] [Full Text] [Related]
20. A Population-Based Helicobacter pylori Eradication Strategy Is More Cost-Effective than Endoscopic Screening.
Kowada A
Dig Dis Sci; 2023 May; 68(5):1735-1746. PubMed ID: 36565366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]